64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer

NCT06970847 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

220

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer
Prostate Cancer Patients With Detectable PSA Following Prostatectomy
Prostate Cancer Recurrent
Prostate Cancer Patients Who Have Brachytherapy Seed Implant
Prostate Cancer Patients Treated by Radiotherapy
Cryotherapy

Interventions

DRUG: 64Cu-SAR-bisPSMA

Sponsor

Clarity Pharmaceuticals Ltd